双能对比增强数字乳腺X线摄影在高风险女性乳腺癌筛查中的性能
这项回顾性研究纳入2012年12月至2016年4月接受双能对比增强数字乳腺X线摄影(CEDM)筛查的女性,评估其筛查性能。共904例基线CEDM,检出15个癌症(检出率15.5/1000),PPV3为29.4%;低能图像敏感度50.0% vs 全部图像(低能+碘图)87.5%(P=.03),特异度93.7%。作者认为CEDM对于筛查风险高于平均水平的女性是有前景的技术。
要点
- CEDM筛查敏感度:低能图像50.0%(8/16)vs 低能+碘图87.5%(14/16),P=.03。
- 特异度93.7%(789/842),PPV1 20.9%(14/67),NPV 99.7%(789/791)。
- 904例中最终BI-RADS 1或2占92.0%,3占2.8%,4或5占5.2%。
核心结论
- 对比增强数字乳腺X线摄影对于筛查风险高于平均水平的女性乳腺癌是一项有前景的技术。
研究设计与样本
- 回顾性研究,纳入2012年12月至2016年4月接受双能CEDM乳腺癌筛查的女性,共904例基线CEDM;平均年龄51.8岁±9.4(标准差);以病历回顾获取年龄、危险因素、建议的短期随访和活检及检出癌症。
关键影像表现/征象
- 904例中700例(77.4%)为致密乳腺,247例(27.3%)有一级亲属50岁或以下乳腺癌家族史,363例(40.2%)有乳腺癌个人史。
- 最终BI-RADS评分1或2为832/904(92.0%),3为25/904(2.8%),4或5为47/904(5.2%)。
- 在14/904名女性中诊断出15个癌症,癌症检出率为15.5/1000。
- PPV3为29.4%(15/51)。
- 858名女性至少有1年随访,期间发生2个间期癌。
诊断标准与关键数值
- 敏感度:低能图像50.0%(8/16;95%CI:24.7%,75.3%)vs 全部研究(低能+碘图)87.5%(14/16;95%CI:61.7%,98.4%),P=.03。
- 特异度93.7%(789/842;95%CI:91.8%,95.2%)。
- PPV1(筛查异常发现的阳性预测值)20.9%(14/67;95%CI:11.9%,32.6%)。
- NPV(阴性预测值)99.7%(789/791;95%CI:99.09%,99.97%)。
- PPV3(活检的阳性预测值)29.4%(15/51)。
临床应用与阅片要点
- 作者认为CEDM是筛查风险高于平均水平女性乳腺癌的有前景技术。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BackgroundContrast agent-enhanced digital mammography (CEDM) has been shown to be more sensitive and specific than two-dimensional full-field digital mammography in the diagnostic setting. Few studies have reported on its performance in the screening setting.PurposeTo evaluate the performance of CEDM for breast cancer screening.Materials and MethodsThis retrospective study included women who underwent dual-energy CEDM for breast cancer screening from December 2012 through April 2016. Medical records were reviewed for age, risk factors, short-interval follow-up and biopsies recommended, and cancers detected. Sensitivity, specificity, positive predictive value of abnormal findings at screening (PPV1), positive predictive value of biopsy performed (PPV3), and negative predictive value were determined.ResultsIn the study period 904 baseline CEDMs were performed. Mean age was 51.8 years ± 9.4 (standard deviation). Of 904 patients, 700 (77.4%) had dense breasts, 247 (27.3%) had a family history of breast cancer in a first-degree relative age 50 years or younger, and 363 (40.2%) a personal history of breast cancer. The final Breast Imaging Reporting and Data System score was 1 or 2 in 832 of 904 (92.0%) patients, score of 3 in 25 of 904 (2.8%) patients, and score of 4 or 5 in 47 of 904 (5.2%) patients. By using CEDM, 15 cancers were diagnosed in 14 of 904 women (cancer detection rate, 15.5 of 1000). PPV3 was 29.4% (15 of 51). At least 1-year follow up was available in 858 women. There were two interval cancers. Sensitivity was 50.0% (eight of 16; 95% confidence interval [CI]: 24.7%, 75.3%) on the low-energy images compared with 87.5% (14 of 16; 95% CI: 61.7%, 98.4%) for the entire study (low-energy and iodine images; P = .03). Specificity was 93.7% (789 of 842; 95% CI: 91.8%, 95.2%); PPV1 was 20.9% (14 of 67; 95% CI: 11.9%, 32.6%), and negative predictive value was 99.7% (789 of 791; 95% CI: 99.09%, 99.97%).ConclusionContrast-enhanced digital mammography is a promising technique for screening women with higher-than-average risk for breast cancer.© RSNA, 2019.
引用
- Sung JS, Lebron L, Keating D, et al. Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer. Radiology. 2019. PMID: 31453765. doi:10.1148/radiol.2019182660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。